<bill session="115" type="s" number="207" updated="2019-04-18T16:32:22Z">
  <state datetime="2018-05-24">REPORTED</state>
  <status>
    <unknown datetime="2018-05-24"/>
  </status>
  <introduced datetime="2017-01-24"/>
  <titles>
    <title type="official" as="introduced">A bill to amend the Controlled Substances Act relating to controlled substance analogues.</title>
    <title type="short" as="reported to senate">SALTS Act</title>
    <title type="short" as="reported to senate">SALTS Act</title>
    <title type="short" as="reported to senate">Synthetic Abuse and Labeling of Toxic Substances Act of 2017</title>
    <title type="short" as="reported to senate">Synthetic Abuse and Labeling of Toxic Substances Act of 2017</title>
    <title type="short" as="introduced">SALTS Act</title>
    <title type="short" as="introduced">Synthetic Abuse and Labeling of Toxic Substances Act of 2017</title>
    <title type="short" as="introduced">Synthetic Abuse and Labeling of Toxic Substances Act of 2017</title>
    <title type="display">SALTS Act</title>
  </titles>
  <sponsor bioguide_id="K000367"/>
  <cosponsors>
    <cosponsor bioguide_id="B001277" joined="2017-01-24"/>
    <cosponsor bioguide_id="C001088" joined="2018-05-24"/>
    <cosponsor bioguide_id="C001056" joined="2017-01-24"/>
    <cosponsor bioguide_id="F000062" joined="2017-01-24"/>
    <cosponsor bioguide_id="G000359" joined="2017-01-24"/>
    <cosponsor bioguide_id="G000386" joined="2017-01-24"/>
    <cosponsor bioguide_id="H001076" joined="2017-02-27"/>
    <cosponsor bioguide_id="H000338" joined="2017-01-30"/>
    <cosponsor bioguide_id="H001061" joined="2018-08-23"/>
    <cosponsor bioguide_id="K000393" joined="2017-06-19"/>
    <cosponsor bioguide_id="M000133" joined="2017-05-15"/>
    <cosponsor bioguide_id="R000595" joined="2017-02-27"/>
    <cosponsor bioguide_id="S001181" joined="2018-08-23"/>
    <cosponsor bioguide_id="S001203" joined="2018-03-07"/>
    <cosponsor bioguide_id="T000476" joined="2017-01-24"/>
    <cosponsor bioguide_id="W000805" joined="2017-01-24"/>
    <cosponsor bioguide_id="W000802" joined="2017-01-24"/>
  </cosponsors>
  <actions>
    <action datetime="2017-01-24">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2017-01-24" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </action>
    <action datetime="2018-04-11">
      <text>Committee on the Judiciary Subcommittee on Crime and Terrorism. Hearings held.</text>
    </action>
    <calendar datetime="2018-05-24" state="REPORTED">
      <text>Committee on the Judiciary. Ordered to be reported without amendment favorably.</text>
    </calendar>
    <action datetime="2018-06-19">
      <text>Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.</text>
    </action>
    <calendar datetime="2018-06-19" calendar="Senate Legislative" under="General Orders" number="472">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 472.</text>
    </calendar>
  </actions>
  <committees>
    <committee subcommittee="" code="SSJU" name="Senate Judiciary" activity="Reporting, Markup, Referral"/>
    <committee subcommittee="Crime and Terrorism" code="SSJU22" name="Senate Judiciary" activity="Hearings"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="unknown" number="2851"/>
    <bill type="h" session="115" relation="unknown" number="6047"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Evidence and witnesses"/>
    <term name="Marketing and advertising"/>
  </subjects>
  <amendments/>
  <summary date="2018-06-19T12:37:37Z" status="Reported to Senate without amendment">Synthetic Abuse and Labeling of Toxic Substances Act of 2017 or the SALTS Act

(Sec. 2) This bill amends the Controlled Substances Act to set forth factors that may be considered as evidence to determine whether a controlled substance analogue is intended for human consumption. (Under current law, a controlled substance analogue that is intended for human consumption is treated as a schedule I controlled substance. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)</summary>
  <committee-reports/>
</bill>
